Oramed Pharmaceuticals (ORMP) Tax Provisions (2016 - 2026)
Oramed Pharmaceuticals (ORMP) reported Tax Provisions of $11.1 million for Q1 2026, up 1805.82% on a YoY basis from $584000.0 in Q1 2025, and up 5350.0% quarter-over-quarter from -$212000.0 in Q4 2025.
Oramed Pharmaceuticals (ORMP) Tax Provisions (2016 - 2026) Analysis & Trends
Oramed Pharmaceuticals has reported Tax Provisions for 6 years, with the latest figure at $11.1 million in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions rose 1805.82% year-over-year to $11.1 million; the trailing twelve-month figure through Mar 2026 stood at $21.9 million (up 480.14% YoY), and the FY2025 full-year result was $11.3 million, up 255.26% from the prior year.
- Tax Provisions for Q1 2026 stood at $11.1 million, up from -$212000.0 in the prior quarter.
- The five-year high for Tax Provisions was $11.1 million in Q1 2026, with the low at -$212000.0 in Q4 2025.
- Historically, Tax Provisions has averaged $2.9 million across 4 years, with a median of $584000.0 in 2025.
- Annual changes were most pronounced in 2025 — Tax Provisions tumbled 150.96% — and 2026, when it jumped 1805.82%.
- Oramed Pharmaceuticals' Tax Provisions stood at $100000.0 in 2022, then jumped by 316.0% to $416000.0 in 2024, then plunged by 150.96% to -$212000.0 in 2025, then surged by 5350.0% to $11.1 million in 2026.
- The last three Tax Provisions figures came in at $11.1 million (Q1 2026), -$212000.0 (Q4 2025), and $11.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Oramed Pharmaceuticals | 149.44 Mn | 131.27 Mn | - | 11.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.13 Mn |
| Dec 31, 2025 | -212,000.00 |
| Sep 30, 2025 | 11.06 Mn |
| Jun 30, 2025 | -126,000.00 |
| Mar 31, 2025 | 584,000.00 |
| Dec 31, 2024 | 416,000.00 |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 1.63 Mn |
| Sep 30, 2022 | 100,000.00 |
| Feb 28, 2019 | 300,000.00 |
| Nov 30, 2016 | 400,000.00 |